Related by context. All words. (Click for frequent words.) 76 Relapsed Refractory 74 Hormone Refractory Prostate Cancer 74 Improves Outcomes 73 Previously Untreated 72 Newly Diagnosed Multiple Myeloma 72 Advanced Melanoma 72 Advanced Colorectal Cancer 71 Complicated Skin 70 Renal Cell Carcinoma 70 Improves Survival 70 Advanced Prostate Cancer 70 Antitumor Activity 70 Follicular Lymphoma 70 Refractory Hodgkin Lymphoma 70 Hormone Receptor Positive 70 Metastatic Renal Cell Carcinoma 70 Myeloma Patients 70 Previously Treated 70 Prolongs Survival 69 FDA Approves Drug 69 Oral Fingolimod 69 HER2 Positive Breast Cancer 69 Treatment Naive Patients 69 Improved Survival 69 Genes Predict 69 Study Evaluating 69 Adjuvant Treatment 69 Rheumatoid Arthritis Patients 69 Liver Metastases 69 Metastatic Colorectal Cancer 69 Survival Benefit 69 Castration Resistant Prostate Cancer 69 Oral Cladribine 69 Soft Tissue Sarcoma 69 Fluorouracil 69 Chronic Hepatitis C 69 Cutaneous T 69 cyclophosphamide doxorubicin vincristine 68 Meets Primary Endpoint 68 Investigational Treatment 68 Peginterferon 68 Lung Cancer Survival 68 Fludarabine 68 Chronic Lymphocytic Leukemia 68 Naive Patients 68 Relapsed 68 Brentuximab Vedotin SGN 68 Novel Oral 68 Advanced Renal Cell 68 HER2 Positive 68 Elderly Patients 68 Pooled Analysis 68 Complete Remission 68 Newly Diagnosed Patients 68 brand ciclesonide HFA 67 Pediatric Patients 67 Relapsing Remitting Multiple Sclerosis 67 Chronic Myeloid Leukemia 67 Carboplatin Paclitaxel 67 Brain Metastases 67 Patients Treated 67 Critically Ill Patients 67 Knee Osteoarthritis 67 Treated Patients 67 Newly Diagnosed Chronic Myeloid 67 Shows Efficacy 67 Phase 2b Clinical Trial 67 Patient Treated 67 Diffuse Large B 67 Shows Promising 67 Chemotherapy Improves 67 Liver Tumors 67 Drug Shows Promise 67 Phase III Trial 67 FDA Okays 67 Adjuvant Therapy 67 indolent follicular non 67 Improve Survival 67 Chronic Cough 67 Patients Receiving 67 Peginterferon Alfa 2b 67 Relapsed Multiple Myeloma 67 Myelofibrosis 67 Anticancer Activity 67 Slow Progression 67 Unresectable 67 Sustained Efficacy 67 Anti Tumor Activity 67 Study Shows Promise 67 Non Hodgkin 67 Trial Evaluating 66 Phase IIb Trial 66 Myelodysplastic Syndromes 66 Premenopausal Women 66 refractory chronic lymphocytic 66 Hepatitis C Genotype 66 Aggressive Prostate Cancer 66 Epratuzumab 66 Enlarged Prostate 66 Investigational Agent 66 Combination Treatment 66 Lupus Nephritis 66 Multiple Myeloma Patients 66 Treatment Shows Promise 66 Treatment Experienced 66 Relapsing Multiple Sclerosis 66 Philadelphia Chromosome Positive 66 Patients Treated With 66 infliximab monotherapy 66 Clinical Trial Results 66 Valopicitabine 66 Appears Safe 66 Dose Escalation 66 Mantle Cell Lymphoma 66 Drug Prevents 66 Breast Cancer Recurrence 66 Drug Candidate 66 Peginterferon Alfa 2a 66 Autologous Stem Cell Transplantation 66 Leukemias 66 Newly Diagnosed 66 Treatment Regimen 66 Patients Suffering 66 Prostate Cancer Patients 66 Anthracycline 66 Completes Patient Enrollment 66 Chronic Lymphocytic Leukemia CLL 66 ZACTIMA TM ZD# 65 Significantly Improved 65 Is Well Tolerated 65 Topline Results 65 Resistant Hypertension 65 Androgen Deprivation Therapy 65 Malignant Melanoma 65 Phase 2a Trial 65 Glufosfamide 65 CYT# potent vascular disrupting 65 Phase III Trials 65 Osteoporosis Drugs 65 Treatment Naïve 65 CVP cyclophosphamide vincristine 65 Decitabine 65 Treatment Reduces 65 Receives Orphan Drug Designation 65 Combination REOLYSIN R 65 Adjunctive Therapy 65 Gastrointestinal Stromal Tumors 65 precursor acute lymphoblastic 65 Bone Metastases 65 Endometrial Cancer 65 Pivotal Study 65 Targeted Therapy 65 Shows Promise Against 65 Pre Cancerous 65 Advanced Ovarian Cancer 65 Postmenopausal Osteoporosis 65 Study Showed 65 Chronic Sinusitis 65 Colorectal Cancer Patients 65 Infected Patients 65 Heart Failure Patients 65 Rheumatoid Arthritis Drug 65 Ovarian Cancer Patients 65 Cyclophosphamide 65 Proves Effective 65 Vaccine Adjuvant 65 Uterine Fibroid Embolization 65 Effectively Treats 65 Slows Progression 65 Subgroup Analysis 65 Hematological Malignancies 65 Drug Combo 65 Pegylated Interferon 65 Inhaled Corticosteroids 65 Radioimmunotherapy 65 Healthbeat Report 65 Mg Usa 65 Phase 2b Trial 65 Adjuvant Chemotherapy 65 GVAX Immunotherapy 65 Patients Undergoing 65 Phase III Clinical Trial 65 Therapy Improves 65 Single Dose 65 Unfractionated Heparin 65 Prostate Cancer Vaccine 65 alfa 2a 65 hematological cancers notably 65 Lowers Risk 65 Sleep Disturbances 65 Neoadjuvant Chemotherapy 65 Nilotinib 64 Overactive Bladder 64 Bosutinib 64 Bevacizumab 64 Kidney Transplant Patients 64 Metastatic Prostate Cancer 64 Cancer Recurrence 64 Tezampanel 64 Reduces Pain 64 Increased Mortality 64 Fungal Infections 64 Anti Tumor 64 Randomized Trials 64 5 FU leucovorin 64 Demonstrates Significant 64 Node Positive 64 Lung Cancer Patients 64 Lung Cancer Trial 64 Fixed Dose 64 stage IIIb IV 64 Chronic Hepatitis B 64 Non Hodgkin Lymphoma 64 Desvenlafaxine Succinate 64 Ulcerative Colitis 64 systemic anaplastic large 64 Demonstrates Potent 64 PEGylated Fab fragment 64 Statistically Significant 64 Phase IIb Clinical Trial 64 Relapsed Refractory Multiple Myeloma 64 Often Misdiagnosed 64 Rituximab 64 dasatinib Sprycel ® 64 Biogen Genentech 64 Hsp# Inhibitor 64 Treatment Resistant 64 Gout Drug 64 Clot Busting 64 Metastatic Melanoma 64 Combo Therapy 64 Gene Linked 64 Initiate Phase III 64 Partial Onset Seizures 64 Monotherapy 64 Chronic HCV 64 Irinotecan 64 resistant hormone refractory 64 Investigational Compound 64 Folfox 64 Pivotal Phase 64 Carotid Stenting 64 Investigational Drug 64 relapsed acute lymphoblastic 64 Prostate Tumors 64 Sustained Reduction 64 Obese Patients 64 Mg Uk 64 Plaque Psoriasis 64 Blood Vessels 64 Ofatumumab 64 PEGylated anti 64 Virus Linked 64 Mouse Model 64 CHOP cyclophosphamide doxorubicin vincristine 64 Versus Placebo 64 Secondary Hyperparathyroidism 64 Initiate Clinical Trial 64 Well Tolerated 64 Ovitrelle R Serostim 64 Patient Enrollment 64 Perifosine KRX 64 Submits NDA 64 Obesity Linked 64 Randomized Study 64 Predict Response 64 R Bortezomib 64 B Cell Malignancies 64 Lung Cancers 64 Localized Prostate Cancer 64 See CLINICAL PHARMACOLOGY 64 Chemotherapy Regimen 64 Less Invasive 64 rituximab refractory 64 Randomized Phase 64 Ovarian Cancers 64 Hedgehog Pathway 64 Bladder Cancer 64 prednisone CHOP 64 Inhalation Aerosol 64 hypertrichosis occurred 64 Atypical Hemolytic Uremic Syndrome 64 Phase 2a Clinical Trial 64 Randomized Phase III 64 relapsed MM 64 Gemcitabine 63 Therapy Shows Promise 63 Demonstrates Positive 63 Placebo Controlled Study 63 ORLive Presents 63 PRN FDA Approves 63 Completes Enrollment 63 Severe Sepsis 63 Camptosar ® 63 Amgen Neulasta R 63 Pemetrexed 63 SPRYCEL ® 63 Paclitaxel Carboplatin 63 Autoimmune Disorders 63 Boosts Survival 63 Stomach Cancer 63 FUSILEV enhances 63 recurrent metastatic ovarian cancer 63 LENALIDOMIDE 63 Metastatic Pancreatic Cancer 63 Bipolar Depression 63 Temodar ® 63 Posaconazole 63 Artery Disease 63 Osteoporosis Drug 63 II Clinical Trial 63 Renal Impairment 63 Receives Positive Opinion 63 Antidepressants Linked 63 Ischemic Stroke 63 Long Term Efficacy 63 Demonstrate Significant 63 HCV Protease Inhibitor 63 Pulmonary Arterial Hypertension 63 TNF Tumor Necrosis Factor 63 Chemoradiation 63 Peginterferon alfa 2b 63 Drug Fails 63 ST Elevation Myocardial 63 Statin Therapy 63 Diabetic Neuropathic Pain 63 atypical Hemolytic Uremic Syndrome 63 Anticancer Drugs 63 Drug Resistant 63 Clinical Trial Evaluating 63 Randomized Phase II 63 Reduces Risk 63 Inflammatory Disease 63 Cell Lymphoma 63 Novel Treatments 63 INSPIRE Trial Phase III 63 Genes Identified 63 Neovascular Age Related Macular 63 Blood Pressure Drug 63 Diabetic Nephropathy 63 Postmenopausal Women 63 Ph + acute lymphoblastic 63 Inflammatory Markers 63 Hypertensive Patients 63 Vildagliptin 63 Lupus Drug 63 Lung Cancer Drug 63 follicular Non Hodgkin 63 Paraplatin ® 63 Drug Coated Stents 63 Poorly Controlled 63 sunitinib Sutent ® 63 Cholesterol Drugs 63 Advanced Pancreatic Cancer 63 Disease Progression 63 known dihydropyrimidine dehydrogenase 63 Telaprevir VX 63 Breast Tumors 63 Diabetic Foot Ulcer 63 Shows Statistically Significant 63 Gastric Cancer 63 Capecitabine 63 Plus Ribavirin 63 NDA Submission 63 Randomized Double Blind 63 Abiraterone Acetate 63 Hepatocellular 63 Personalized Immunotherapy 63 FOLFOX6 63 Genes Associated 63 Prophylactic Treatment 63 evaluating picoplatin 63 Acute Attacks 63 LymphoStat B belimumab 63 Protein Linked 63 Transplant Patients 63 R rilonacept Injection 63 Cocaine Addiction 63 Tipranavir 63 carcinoma mCRC 63 Phase 2b Study 63 Predict Prostate Cancer 63 Severe Asthma 62 Transdermal Patch 62 Xeloda ® 62 Hyperlipidemia 62 Oral Laquinimod 62 JAK Inhibitor 62 Experimental Vaccine 62 Lymphocytic 62 Genes Linked 62 Nicotine Vaccine 62 Albuferon TM 62 Gene Mutation Linked 62 Solid Tumors 62 topical gel formulation 62 Serious Infections 62 Demonstrated Significant 62 Acute Exacerbations 62 Prolongs Life 62 Blood Clots 62 Gene Mutations 62 refractory NSCLC 62 Radical Prostatectomy 62 Protease Inhibitor 62 Tumor Growth 62 lymphoma multiple myeloma 62 Osteoporosis Treatment 62 Improve Outcomes 62 Nerve Pain 62 Physician Insights 62 BCG refractory carcinoma 62 Preclinical Study 62 Chronic Myelogenous Leukemia 62 Acute Heart Failure 62 FDA Approvals 62 Diabetic Patients 62 Subarachnoid Hemorrhage 62 Emerging Therapies 62 DOXIL ® 62 Detect Lung Cancer 62 Epilepsy Drugs 62 TO AVOID PREGNANCY WHILE 62 Wafer polifeprosan 62 Hepatitis C Patients 62 Polymerase Inhibitor 62 Gene Mutation 62 PROCTOCORT ® Suppository Hydrocortisone 62 Crofelemer budesonide foam 62 Platinol ® 62 Metastatic Breast Cancer 62 Granted Orphan Drug 62 Autoimmune Disease 62 Initiate Phase 62 ovarian esophageal 62 Brain Atrophy 62 Kit CD# positive 62 Prospective Randomized 62 Generalized Anxiety Disorder 62 Azacitidine 62 Melphalan 62 Left Ventricular Hypertrophy 62 developing Bicifadine serotonin 62 metastatic GIST 62 refractory cutaneous T 62 previously untreated follicular 62 Predict Risk 62 Gene Variant 62 Sirolimus Eluting Stent 62 Blood Pressure Drugs 62 metastatic pancreatic 62 Chronic Inflammation 62 Immunomedics Announces 62 Interferon Beta 62 Idiopathic Pulmonary Fibrosis 62 Exercise Reduces 62 Calcium Vitamin D 62 Randomized Clinical Trials 62 Files IND 62 included exfoliative dermatitis 62 Neoadjuvant 62 Kidney Transplants 62 FDA Clears 62 Barr Receives Approval 62 Tolerability 62 Cell Transplants 62 Advanced Solid Tumors 62 hormone refractory metastatic prostate 62 STELARA TM 62 Meta Analysis 62 Natalizumab 62 Potentially Fatal 62 Nymox NX 62 Gemzar ® 62 Gum Disease 62 Vitrasert R 62 Seasonal Allergic Rhinitis 62 Bone Fractures 62 Treatment Naive 62 gastrointestinal stromal 62 Demonstrates Potential 62 imatinib Gleevec ® 62 Skin Cancers 62 Stem Cells Used 62 Monoclonal Antibody 62 Ribavirin causes 62 Cell Non Hodgkin 62 rilonacept Injection 62 Antipsychotic Drug 62 pralatrexate injection folate analogue 62 metastatic malignant 62 Soy Isoflavones 62 8mg/kg 62 Gene Variation 62 Molecular Diagnostic Test 62 steroid refractory ulcerative 62 sorafenib tablets 62 R lenalidomide 62 Viral Load 62 Lymphoid 62 Recurrent Breast Cancer 62 Reduced Risk 62 Acute Myeloid Leukemia 62 Shows Promise 62 Initiates Clinical Trial 62 Alemtuzumab 62 CG# oncolytic virus 62 intravesical infusion therapy 61 Efficacious 61 Muscle Function 61 Leukemia AML 61 Glioblastoma Multiforme 61 Smoking Linked 61 Lymph Nodes 61 Intravitreal 61 ® lenalidomide 61 PEGINTRON TM 61 Asthma Symptoms 61 Vandetanib 61 Induction Therapy 61 registrational Phase 61 Randomized Double blind 61 ® bortezomib 61 include Healive TM 61 Tissue Engineered 61 Initiates Enrollment 61 Solid Malignancies 61 Study Demonstrates 61 Pharmacokinetics PK 61 radioimmunotherapeutic agent 61 Newly Diagnosed Breast Cancer 61 Malignant Glioma 61 R Saizen R 61 Demonstrates Sustained 61 Demonstrates Efficacy 61 Benign Prostatic Hyperplasia 61 myocardial infarction ventricular fibrillation 61 Levels Linked 61 Placebo Controlled Trial 61 Treatment Naive HIV 61 Survival Rates 61 IMiDs ® 61 Myelodysplastic Syndrome 61 FDA Accepts 61 Golimumab 61 NICE Recommends 61 relapsed Acute Myeloid 61 Hepatocellular Carcinoma 61 Sangamo BioSciences Announces 61 Statin Drugs 61 Diabetic Kidney Disease 61 Physical Function 61 Basal Cell 61 Teva Provides Update 61 Certain Cancers 61 Anti TNF 61 Breast Cancers 61 Androgen Deprivation 61 Combination Therapy 61 Aflibercept 61 Vertebral Fractures 61 Lymphoma Patients 61 Submits Biologics License Application 61 Mayo Clinic Study Finds 61 Intracranial Aneurysms 61 Rheumatoid Arthritis RA 61 J Shoulder Elbow 61 Cardiovascular Events 61 Spectrum Pharmaceuticals Announces 61 By JENNIFER LEARN 61 Squamous Cell Carcinoma 61 cyclophosphamide methotrexate 61 Therapeutic Efficacy 61 Double Blind Placebo 61 Myelodysplastic Syndrome MDS 61 irinotecan doxorubicin oxaliplatin paclitaxel 61 Metastatic 61 Colorectal Cancer Risk 61 Recombinant Human 61 Omacetaxine 61 plus prednisone prednisolone 61 Tumor Response 61 Trastuzumab 61 Vidaza ® 61 Tyrosine Kinase Inhibitors 61 Breast Cancer Patients 61 Pivotal Phase III 61 Stem Cell Transplants 61 interferon beta 1a infertility 61 Brain Tumor Patients 61 Genetic Mutations 61 Neuroendocrine Tumors 61 Disease Modifying 61 Erectile Dysfunction Drug 61 Psoriasis Patients 61 metastatic castration resistant 61 approved incretin mimetic 61 Increases Risk 61 essential thrombocythemia ET 61 AAG geldanamycin analog 61 MyVax R 61 refractory acute lymphoblastic 61 basal cell carcinoma squamous 61 Predict Breast Cancer 61 Phase IIa Clinical Trial 61 Zoledronic Acid 61 REMINDER ORLive Presents 61 Zorbtive TM 61 Vitro Activity 61 Chronic Renal Failure 61 TNF Blockers 61 Ozarelix 61 Voreloxin 61 Interferon beta 1a 61 Regimens 61 Levoleucovorin 61 bone marrow reticulin deposition 61 Atopic Dermatitis 61 Migraine Pain 61 Protein Involved 61 Cytarabine 61 Carcinomas 61 Systemic Sclerosis 61 Pertuzumab 61 Analytical Tool 61 Renal Cancer 61 Pulmonary Artery 61 Romiplostim 61 Test Detects 61 Gene Therapy Trial 61 Migraine Headaches 61 Radiofrequency Ablation 61 Treating Chronic 61 CYP#A# CYP#D# 61 Minimally Invasive Procedure 61 Diabetic Foot Ulcers 61 Blood Thinner 61 Multicenter Trial 61 Key Attributes 61 Inhibits 61 leukopenia pancytopenia thrombocytopenia 61 AnaSpec Introduces 61 Elotuzumab 61 lintuzumab SGN 61 ALN HPN 61 cancer mCRC 61 Cognitive Function 61 erlotinib Tarceva ® 61 Fludara ® 61 Childhood Leukemia 61 achieved CCyR 61 CHOP chemotherapy 61 Bronchiectasis 61 B Cell Lymphoma 61 Genetic Variations 61 Novel Compound 60 HDAC Inhibitor 60 Anticancer Drug 60 Hypercholesterolemia 60 Mouse Models 60 substantially excreted 60 Preclinical Data 60 Presents Positive 60 evaluating Xcytrin 60 humanized therapeutic 60 Obese Teens 60 Invasive Breast Cancer 60 undergoing hematopoietic stem 60 Organ Rejection 60 Capsules CII 60 Contrast Agent 60 Moderate Drinking 60 Bone Marrow Transplants 60 Significantly Reduces 60 Balloon Angioplasty 60 Juvenile Idiopathic Arthritis 60 ST Segment Elevation 60 Orthop Surg 60 Endothelial Cells 60 Prognostic Significance 60 cisplatin gemcitabine 60 Enzo Biochem Reports 60 Anflu R influenza 60 Invasive Fungal Infections 60 EntreMed Presents 60 Pharmacokinetic Study 60 Oral Formulation 60 Copegus ® 60 Breast Cancer Treatment 60 Initiates Phase III 60 Platelet Inhibition 60 Stromal Cells 60 Adalimumab 60 Vaccine Shows Promise 60 galiximab 60 Hematological Cancers 60 vascular occlusive diseases 60 5 Fluorouracil 60 YOUR LOCAL ANIMAL SHELTER 60 relapsed refractory aggressive 60 Lenalidomide 60 Diabetic Macular Edema 60 VANTAS ® 60 plus prednisone 60 tumor xenograft models 60 leukemia AML 60 Pruvel TM 60 Anthrax Toxin 60 de novo kidney transplant 60 Nuvelo Announces 60 Squamous 60 Visceral Fat 60 Wound Dressing 60 Genetic Disorder 60 Reovirus 60 Pivotal Trial 60 metastatic ocular 60 Daclizumab 60 IMiDs ® compound 60 Ranolazine 60 docetaxel Injection Concentrate 60 Antifungals 60 Minimally Invasive Treatment 60 neutropenia dehydration dyspnea 60 Low Dose 60 Ibritumomab Tiuxetan 60 CTAP# Capsules 60 Pharmacyclics Announces 60 Hemodialysis Patients 60 oral proteasome inhibitor 60 Antiplatelet Therapy 60 Chemotherapeutic Agents 60 Renal Cell Cancer 60 Sevelamer 60 Vicriviroc 60 Antidepressant Use 60 interferon gamma 1b 60 pegylated liposomal doxorubicin 60 Chronic lymphocytic leukemia 60 Inhaled Nitric Oxide 60 J Antimicrob Chemother 60 Immune Cells 60 Genetic Variant 60 Cholesterol Levels 60 Renal Function 60 Brain Scans 60 deCODE ProstateCancer TM 60 Preclinical Models 60 Vitamin D Linked 60 Xelox 60 Subtypes 60 trastuzumab Herceptin R 60 FOLFIRI alone 60 Temsirolimus 60 Osteoarthritis Patients 60 Septic Shock 60 JAK2 Inhibitor 60 Acute Myeloid Leukemia AML 60 MEK Inhibitor 60 VEGFR2 inhibitor 60 Soyabean Ext Bulk 60 Orally Active 60 Non Responders 60 Tyrosine Kinase Inhibitor 60 Panic Disorder 60 standard chemotherapy regimen 60 Magnetic Stimulation 60 Kidney Stones 60 small lymphocytic lymphoma 60 Premature Babies 60 Liver Damage 60 Knee Arthritis 60 Preterm Delivery 60 sapacitabine CYC# 60 Prognostic Value 60 Vascular Grafts 60 Sipuleucel T 60 mitoxantrone plus 60 Multicenter Randomized 60 Abdominal Pain 60 cyclophosphamide FC 60 Pregnancy Linked 60 prednisone prednisolone plus 60 Prostate Cancer Survival 60 Telik logo TELINTRA 60 Navelbine ® 60 Colorectal Cancers 60 oropharyngeal candidiasis OPC 60 anthracycline derivative 60 metastatic hormone refractory 60 Controlled Trial 60 Vaccine Prevents 60 Potent Anti 60 Present Preclinical Data 60 Treating Prostate Cancer 60 Papillary 60 CIMZIA ™ 60 Prostate Biopsy 60 Pegasys ® 60 Poniard Pharmaceuticals Announces 60 relapsed leukemia 60 AVASTIN 60 leukemia CLL 60 Rectal Cancer 60 Treat Heart Failure 60 Pivotal Clinical Trial 60 Node Negative 60 Anal Cancer 60 FDA Approves Novel 60 Vertebral Compression Fractures 60 chronic myeloid 60 Testosterone Therapy 60 Irregular Heartbeat 60 FOLFOX6 chemotherapy regimen 60 Hemolysis 60 rituximab refractory follicular 60 Fortical ® Unigene nasal 59 metastatic renal 59 Acute Ischemic Stroke 59 Taro Receives 59 acute peptic ulcer 59 investigational oral inhibitor 59 Cardiotoxicity 59 candidates Azedra 59 Breast Cancer Cells 59 Antiviral Activity 59 Treatable 59 Hepatitis C Infection 59 Thyroid Cancer 59 candidates Azedra TM 59 Prednisone Against Refractory 59 Ovarian Cancer Risk 59 Prove Effective 59 temsirolimus Torisel 59 ATRA IV 59 Acute myelogenous leukemia 59 ISTODAX ® 59 Colorectal Adenomas 59 unresectable tumors 59 metabolic alkalosis 59 Cognitive Impairment 59 Migraine Headache 59 Progenitor Cells 59 stage IIIB 59 unresectable stage 59 Rare Genetic 59 Hyperthermia Therapy 59 Patient Outcomes 59 MRSA Infections 59 Autoimmune Diseases 59 systemic juvenile idiopathic 59 Patrick Swayze Dies 59 Dose Ranging Study 59 FOLFIRI 59 relapsed multiple myeloma 59 low dose cytarabine 59 Fast Track Status 59 melphalan prednisone 59 Remission Maintenance 59 lenalidomide Revlimid R 59 T Cell Lymphoma 59 Reduces Mortality 59 Endocrinol 59 Budesonide foam crofelemer 59 unique alkylating agent 59 humanized interleukin 6 59 Adenoma 59 Racivir 59 HPV Infection 59 bortezomib refractory 59 cytarabine daunorubicin 59 Telik Announces 59 Accurate Diagnosis 59 Pancreatic Adenocarcinoma 59 Novel Mechanism 59 vitreoretinal disorders 59 Multiple Myeloma MM 59 Stem Cell Treatment 59 familial amyloidotic polyneuropathy FAP 59 Randomized Controlled 59 Amrubicin 59 evaluating tivozanib 59 ara C 59 Statin Use 59 5 fluorouracil leucovorin 59 Heel Pain 59 myelodysplastic myeloproliferative diseases 59 Cholangiocarcinoma 59 Peanut Allergies 59 Circulating Tumor Cells 59 Transplant Rejection 59 Effective Treatments 59 Tesetaxel 59 NMIBC 59 5-FU/LV 59 unresectable Stage III 59 pegylated interferon alfa 2a 59 reduce serum phosphate 59 Regenerative Cells 59 Aztreonam Lysine 59 Recurrent Prostate Cancer 59 Nebulized 59 Meet Primary Endpoint 59 Excessive Sweating 59 Psoriasis Drug 59 Zarnestra 59 Genetic Variants 59 Immunosuppressant 59 liver colon rectal 59 External Beam 59 DOXIL 59 Coronary Stents 59 novel nucleoside analog 59 Be Cured 59 Combination Clinical Trial 59 Hypertrophy 59 cell lymphoma CTCL 59 Neurol 59 Pregnancy Complication 59 Humanized Anti 59 Eculizumab 59 GW# [003] 59 CIMZIA r certolizumab pegol 59 Central Venous Catheters 59 Plicera TM 59 Increased Risk 59 Drug Resistant TB 59 including cyclosporine methotrexate 59 Blood Cancers 59 MabThera Rituxan 59 toenail onychomycosis 59 Kidney Function 59 hA# 59 Elagolix 59 Pegylated Liposomal Doxorubicin 59 RAS MAPK pathway 59 Oral Mucositis 59 Neovascular 59 FEMALES SHOULD BE ADVISED 59 Chronic Bronchitis 59 cyclophosphamide doxorubicin 59 Mitral Regurgitation 59 Safinamide 59 Bortezomib 59 cytidine nucleoside analog 59 INDUSTRY ASSESSMENTS 59 Endovascular Treatment 59 Bleeding Disorder 59 Derma Sciences Announces 59 HER2 positive metastatic breast 59 Pirfenidone 59 sarcoma melanoma 59 mGluR5 negative 59 Acute Myelogenous Leukemia 59 dasatinib Sprycel 59 Cancer Patients Treated 59 Tanespimycin 59 Sapacitabine 59 dexamethasone Decadron 59 Follicular 59 Progressive Multifocal Leukoencephalopathy 59 Cancer Treatments 59 Hepatitis C Virus 59 Contrast Agents 59 SinuNase TM 59 Diabetic Ulcers 59 metastatic castrate resistant 59 Childhood Trauma 59 chronic lymphocytic 59 Anthracyclines 59 Controlled Study 59 significant cytopenia eg 59 Ischemic 59 Flu Cy 59 Aspirin Reduces 59 XL# anticancer compounds 59 Epidermal Growth Factor Receptor 59 Urinary Incontinence 59 Bivalirudin 59 Colon Polyps 59 Int J Radiat Oncol 59 Virus Infection 59 Antigen Specific 59 Acute myeloid leukemia 59 Cognitive Decline 59 Shown Effective 59 Liver Failure 59 Disease IBD 59 Launches Generic Version 59 Electrical Stimulation 59 Bacterial Infections 59 Dupuytren Disease 59 Navelbine 59 Vaccine Protects Against 59 Potentially Deadly 58 Cancer Incidence Mortality 58 Xeloda capecitabine 58 Blood Pressure Lowering 58 oncolytic virus therapies